
### [NCIT:C2862](http://purl.obolibrary.org/obo/NCIT_C2862)
**Label:** Primary Myelofibrosis

**Subclasses:** [NCIT:C41238](http://purl.obolibrary.org/obo/NCIT_C41238) (Primary Myelofibrosis, Overt Fibrotic Stage), [NCIT:C41237](http://purl.obolibrary.org/obo/NCIT_C41237) (Primary Myelofibrosis, Prefibrotic/Early Stage), 

**Class expressions from DL-Learner:**

- Thing 53.49%
- [NCIT:C36524](http://purl.obolibrary.org/obo/NCIT_C36524) (Loss of Chromosome 7) 52.63%
- [NCIT:C36521](http://purl.obolibrary.org/obo/NCIT_C36521) (Partial Trisomy 1q) 52.63%
- [NCIT:C36497](http://purl.obolibrary.org/obo/NCIT_C36497) (Loss of Chromosome 13q) 52.63%
- [NCIT:C36455](http://purl.obolibrary.org/obo/NCIT_C36455) (Gain of Chromosome 8) 52.63%
- [NCIT:C36403](http://purl.obolibrary.org/obo/NCIT_C36403) (Loss of Chromosome 20q) 52.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.99%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 37.99%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 37.99%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 37.99%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 37.99%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 37.99%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 37.99%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 37.99%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 37.99%


